Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain

Summary

The purpose of this study is to test whether LY3526318 is efficacious and safe in relieving chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

Timeline

Start

2021-10-25

Primary completion

2022-06-17

Completion

2022-06-17

Outcome

Missed primary endpoint

registry analysis (superiority test); 250 mg LY3526318 vs Placebo; Posterior Mean Difference -0.38 (95% CI -0.89 to 0.13) NCT05086289 ↗

Drugs

Indications